 <h1>Belantamab mafodotin Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to belantamab mafodotin: intravenous powder for injection</i></p><h3>Warning</h3><p>An eye doctor will need to examine your eyes before each dose of this medicine. Belantamab mafodotin can cause eye problems that may lead to blurred vision, an ulcer on the surface of your eye, or vision loss.</p><p>Get emergency medical help if you have signs of an allergic reaction:  hives; difficult breathing; swelling of your face, lips, tongue, or throat.</p><p>Some side effects may occur during the injection (infusion reaction).  Tell your caregiver if you feel dizzy, tired, nauseated, light-headed, itchy, feverish, chilled, sweaty, short of breath, or have racing heartbeats, trouble breathing, or swelling in your face.</p><p>Call your doctor at once if you have:</p><ul>
<li>
<p>sudden vision loss;</p>
</li>
<li>
<p>easy bruising, unusual bleeding; or</p>
</li>
<li>
<p>signs of bleeding in the brain--weakness, dizziness, confusion, numbness or tingling on one side of the body, loss of movement in your face.</p>
</li>
</ul><p>sudden vision loss;</p><p>easy bruising, unusual bleeding; or</p><p>signs of bleeding in the brain--weakness, dizziness, confusion, numbness or tingling on one side of the body, loss of movement in your face.</p><p>Tell your eye doctor if you have any eye problems, changes in your vision, dry eyes, or vision loss.</p><p>Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.</p><p>Common side effects may include:</p><ul>
<li>
<p>vision changes;</p>
</li>
<li>
<p>eye changes found during an eye exam;</p>
</li>
<li>
<p>infusion reaction;</p>
</li>
<li>
<p>abnormal lab tests;</p>
</li>
<li>
<p>fever, tiredness; or</p>
</li>
<li>
<p>nausea.</p>
</li>
</ul><p>vision changes;</p><p>eye changes found during an eye exam;</p><p>infusion reaction;</p><p>abnormal lab tests;</p><p>fever, tiredness; or</p><p>nausea.</p><p>This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to belantamab mafodotin: intravenous powder for injection</i></p><h3>Ocular</h3><p><b>Very common</b> (10% or more): Ocular adverse reactions (77%), keratopathy (based on slit lamp eye examination and characterized as corneal epithelium changes with or without symptoms) (76% all Grades; 44% Grade 3 or 4), decreased visual acuity (53% all Grades; 28% Grade 3 or 4), blurred vision (e.g., diplopia, vision blurred, visual acuity reduced, visual impairment (22% all Grades; 4% Grade 3 or 4), dry eye (e.g., dry eye, ocular discomfort, eye pruritus) (14% all Grades 1% Grade 3 or 4)</p><p><b>Common</b> (1% to 10%): Photophobia, eye irritation, infective keratitis, ulcerative keratitis<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Thrombocytopenia (69% all Grades, 13% Grade 2, 10% Grade 3, 17% Grade 4), platelets decreased (62%), lymphocytes decreased (49%), hemoglobin decreased (32%), neutrophils decreased (28%)<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Frequency not reported</b>: Potential for immunogenicity<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Infusion related reactions (IRRs) (e.g., infusion-related reaction, pyrexia, chills, diarrhea, nausea, asthenia, hypertension, lethargy, tachycardia) (21%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia (12%), back pain (11%)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Albumin decreased (43%), glucose increased (38%), sodium decreased (21%), potassium decreased (20%), anorexia (12%)<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Albuminuria<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Aspartate aminotransferase increased (57%), alkaline phosphatase increased (26%), gamma-glutamyl transferase increased (25%)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (e.g., upper respiratory tract infection, nasopharyngitis, rhinovirus infections, sinusitis (11%)</p><p><b>Common</b> (1% to 10%): Pneumonia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Pyrexia (22%), fatigue/asthenia (20%)<sup>[Ref]</sup></p><h3>General</h3><p>This drug caused serious adverse reactions in 40% of patients.  Serious adverse reactions in 3% or more of patients included pneumonia (7%), pyrexia (6%), renal impairment (4%), sepsis (4%), hypercalcemia (4%), and infusion-related reactions (3%).  Fatal adverse reactions occurred in 3.2% of patients, including sepsis (1%), cardiac arrest (1%), and lung infection (1%).<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Creatinine increased/creatinine phosphokinase increased (22%)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Infusion related tachycardia<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (24%), constipation (13%), diarrhea (13%)</p><p><b>Common</b> (1% to 10%): Vomiting<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Blenrep (belantamab mafodotin)." GlaxoSmithKline, Research Triangle Park, NC. </p><h2>More about belantamab mafodotin</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>1 Review</li>
<li>Drug class: miscellaneous antineoplastics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Belantamab mafodotin-blmf Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Multiple Myeloma</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>